We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
P
126
PUT
Everpure Inc
P
$25.7B
| $4.58M | 0.23% |
+300,000
| New | +$5.86M |
|
|
EE
127
DELISTED
El Paso Electric Company
EE
| $4.58M | 0.23% |
+70,000
| New | +$4.3M |
|
128
PG&E
PCG
$38.3B
| $4.56M | 0.23% |
198,900
-147,600
| -43% | -$2.97M |
|
129
PUT
Varex Imaging
VREX
$472M
| $4.56M | 0.23% |
148,700
-113,800
| -43% | -$3.47M |
|
|
NVRO
130
PUT
DELISTED
NEVRO CORP.
NVRO
| $4.54M | 0.23% |
+70,000
| New | +$4.36M |
|
131
CALL
Coty
COTY
$2.42B
| $4.49M | 0.23% |
334,800
+84,800
| +34% | +$1.04M |
|
132
PUT
Devon Energy
DVN
$52.1B
| $4.49M | 0.23% |
+157,300
| New | +$4.67M |
|
133
Newmont
NEM
$98.7B
| $4.42M | 0.22% |
+115,000
| New | +$3.89M |
|
|
BHVN
134
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.35M | 0.22% |
99,300
-700
| -0.7% | -$39.5K |
|
|
PTLA
135
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.34M | 0.22% |
+160,000
| New | +$5.02M |
|
136
CALL
Okta
OKTA
$24.7B
| $4.32M | 0.22% |
+35,000
| New | +$3.8M |
|
137
CALL
Adient
ADNT
$1.65B
| $4.32M | 0.22% |
+177,800
| New | +$3.66M |
|
|
TVRD
138
CALL
Tvardi Therapeutics
TVRD
$19.7M
| $4.3M | 0.22% |
+5,556
| New | +$3.9M |
|
|
TVRD
139
PUT
Tvardi Therapeutics
TVRD
$19.7M
| $4.3M | 0.22% |
+5,556
| New | +$3.9M |
|
140
PUT
Autohome
ATHM
$2.67B
| $4.28M | 0.22% |
+50,000
| New | +$4.98M |
|
141
CALL
Alarm.com
ALRM
$2.71B
| $4.28M | 0.22% |
80,000
| – | – |
|
|
SFLY
142
DELISTED
Shutterfly, Inc.
SFLY
| $4.28M | 0.22% |
84,600
+60,600
| +253% | +$2.77M |
|
143
PUT
Exelixis
EXEL
$13.3B
| $4.27M | 0.22% |
200,000
+150,000
| +300% | +$3.14M |
|
144
CALL
Paychex
PAYX
$41.6B
| $4.21M | 0.21% |
+51,100
| New | +$4.31M |
|
145
Unum
UNM
$13.6B
| $4.19M | 0.21% |
+125,000
| New | +$4.33M |
|
|
SIX
146
DELISTED
Six Flags Entertainment Corp.
SIX
| $4.19M | 0.21% |
84,260
-80,200
| -49% | -$4.14M |
|
147
PUT
Penumbra
PEN
$12.7B
| $4.18M | 0.21% |
+26,100
| New | +$3.77M |
|
|
ITCI
148
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.17M | 0.21% |
321,700
+120,200
| +60% | +$1.54M |
|
149
Viatris
VTRS
$20.4B
| $4.13M | 0.21% |
+217,000
| New | +$4.8M |
|
150
CALL
Polaris
PII
$3.82B
| $4.11M | 0.21% |
+45,000
| New | +$4.1M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.